November is Lung Cancer Awareness Month
This Lung Cancer Awareness Month might look and feel a little different than in the past, but we know, no matter the circumstances, the lung cancer community remains resilient and passionate about creating better outcomes for those affected by lung cancer.
LUNGevity has many opportunities for you to share important information and highlight stories of those affected by lung cancer this Lung Cancer Awareness Month.
Join the LUNGevity Action Network
You can take real steps towards improving lives and outcomes for people with lung cancer by joining the LUNGevity Action Network. You can help raise public awareness by sharing your story, posting on social media, completing surveys, and more. You can also learn about important issues, sign petitions, comment on regulations, and write your legislators about what matters to you.
Learn more at lungevity.org/actionnetwork.
Get the facts and stay engaged
LUNGevity has all the information you need to be engaged during Lung Cancer Awareness Month. Learn more about lung cancer by checking out our lung cancer statistics or checking our Lung Cancer 101 page. Learn more about LUNGevity and how to stay engaged by reading our blogs and checking out the website for updates and important information for patients and caregivers.
Spread the word
Using the power of social media, you can spread lung cancer awareness and encourage others to become engaged to help stop lung cancer. Share lung cancer facts and advancements, encourage your friends and family to get involved, and spread the hope of a better tomorrow. Use our pre-written posts and graphics or create your own. Don’t forget to tag @LUNGevity!
Attend a virtual event
Learn more about lung cancer at our Facebook Live events:
- Learn more about the basics of comprehensive biomarker testing at Tumors & Testing: the Basics of Comprehensive Biomarker Testing in Lung Cancer Care, featuring LUNGevity President and CEO Andrea Ferris speaking with lung cancer patient and advocate Sarah Christ, oncologist Dr. Raymond Osarogiagbon, and David Raben, VP Product Development at Genentech on November 18.
- Join us for a conversation with Andrea Ferris and Dr. Avi Spira, Global Head of the Lung Cancer Initiative at Johnson & Johnson, that is dedicated to the prevention, interception and cure of lung cancer. They’ll discuss advances in early detection and treatment, and what the future may hold in lung cancer research. The date will be announced on Facebook later this week – follow us so you don’t miss it!
